◆ TICKERBASE · US STOCK FINANCIAL DATA LIBRARY

HomeAll stocks › TXMD

TherapeuticsMD, Inc. (TXMD) Financial History

4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.

Healthcare · Drug Manufacturers - Specialty & Generic · DATA UPDATED 2026-07-10

TherapeuticsMD, Inc. (TXMD) operates in the Drug Manufacturers - Specialty & Generic industry and is headquartered in Boca Raton, United States with about 1 employees. Its market capitalization is roughly $23 million. In the fiscal year ended 2025-12-31, TXMD reported $3M in revenue and ($1M) in net income.

TherapeuticsMD, Inc. operates as a pharmaceutical royalty company in the United States and internationally.

Interactive charts & full statements → Open the TXMD valuation workbench →

TXMD Revenue & Earnings History — Annual Income Statement

Income statement2025-12-312024-12-312023-12-312022-12-312021-12-31
Total Revenue$3M$2M$1M$70M
Gross Profit$1M$69M$1M
Operating Income (EBIT)($4M)($5M)($8M)$11M
Net Income($1M)($2M)($10M)$112M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

TXMD Quarterly Revenue & Earnings — Last 8 Quarters

Quarterly income statement2026-03-312025-12-312025-09-302025-06-302025-03-31
Total Revenue$1M$1M$1M$1M$0M
Operating Income (EBIT)($1M)($2M)($1M)($1M)($1M)
Net Income$0M($1M)$0M$1M($1M)

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

TXMD Free Cash Flow History

TXMD Balance Sheet History

Balance sheet2025-12-312024-12-312023-12-312022-12-312021-12-31
Total Assets$38M$39M$43M$90M
Total Liabilities$11M$12M$14M$55M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive TXMD viewer.

Other Companies in Drug Manufacturers - Specialty & Generic

← TXGAll stocksTXN →

About TickerBase · Data methodology & sources

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.